Primaire tabs

Zoeken
Limit to
Exporteer 63 resultaten:
Filters: Auteur is L. Tesolin
2023
Comment implémenter l'analyse de tendance, Tesolin, L., and Auquier J. , Webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
Development of a multiplex-based immunoassay for the characterization of diphtheria, tetanus and acellular pertussis antigens in human combined DTaP vaccines., Vermeulen, Maxime, Feck Isabelle, Francotte Antoine, Hassall Laura, Tesolin L., Van Molle Wim, Pizzato Romain, Laurent Thierry, Hoebreck Charline, Stickings Paul, et al. , J Immunol Methods, 2023 Jun, Volume 517, (2023)
EU batch release procedure: Annual Report 2 - Batch Release of Vaccines, Waeterloos, Geneviève, Auquier J., Domicent C., Cuignet L., Clouet S., Desmet N., Florens Morgane, Laurent F., Masquelier F., Ribaucour F, et al. , 2023 05 25, p.314, (2023)
l'analyse de tendance-concepts préliminaires, Tesolin, L., and Desmet N. , webinar ARP Senegal, 12/09/2023, Sciensano, Brussels, (2023)
OCABR: Respiratory Syncytial Virus (rDNA) Vaccine, Tesolin, L., Garcia D., Oppling V., Bruysters M., Pullirsch D., and Campitelli L. , 29/09/2023, Strasbourg (F), p.15, (2023)
Phase 2 testing: where are we now?, Bruysters, M., Tesolin L., and Lange J. , OMCL Annual Meeting EDQM 2023, 06/2023, Madrid, SPain, (2023)
Rational arguments for regulatory acceptance of consistency testing: benefits of non-animal testing over release testing of vaccines., Hoefnagel, Marcel H. N., Stickings Paul, Smith Dean, Jungbäck Carmen, Van Molle Wim, and Tesolin L. , Expert Rev Vaccines, 2023 Apr 03, Volume 22, Issue 1, Number 377, (2023)
Report of WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines, Tesolin, L., Meyer H., Lei D., Jivapaisarnpong T., Welin M., and Cheung A. , 10/10/2023, Geneva, switzerland, p.9, (2023)
A roadmap for regulatory implementation of in vitro models for evaluation of vaccine efficacy, Vandebriel, R. J., Tesolin L., Veenstra K., and Huber K. , 08/2023, Niagara falls, Canada, (2023)
Training on the assessment of quality part (M3) of the eCTD for the registration of vaccines for human use, Brusselmans, Koen, Van Molle Wim, and Tesolin L. , Training on The assessment of quality part (M3) of the eCTD for the registration of vaccines for human use, 15/11/2023, Brussels, Belgium, (2023)
The vaccine Batch release procedure in Europe, Tesolin, L. , Seminaire etudiants en pharmacie ULB, 04/12/2023, Brussels, Belgium, (2023)
WHO Drafting Group meeting to revise WHO Guidelines on PAC- outcome of workshops, Tesolin, L. , WHO Drafting Group meeting to revise WHO Guidelines on procedures and data requirements for changes to approved vaccines, 20/09/2023, Frankfurt, Germany, (2023)
2022
Auditors experience with remote audits ‘Preparatory phase’ , Waeterloos, Geneviève, Tesolin L., and Van Molle Wim , OMCL annual meeting 2022, 14/06/2022, EDQM, strasbourg, (2022)
The batch release procedure in Europe, Tesolin, L. , Seminaire etudiants en pharmacie ULB, 05/12/2022, Brussels, Belgium, (2022)
The change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Q&A, Tesolin, L., and Bruysters M. , OMCL annual meeting 2022, 16/06/2022, EDQM, strasbourg, (2022)
Concept paper on the change in testing strategy for purity test on monovalent bulk of recombinant protein vaccine, Tesolin, L., and Bruysters M. , 06/04/2022, Strasbourg, France, p.5, (2022)
The consistency approach for the substitution of in vivo testing for the quality control of established vaccines: practical considerations and progressive vision, Tesolin, L., Dierick J.-F., and Van Molle Wim , Open Research Europe, 13/12/2022, (2022)
Manufacture and control of vaccine adjuvants from OMCL perspective, Tesolin, L. , Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
OCABR guideline for inactivated COVID-19 vaccines, Pullirsch, D., Campitelli L., Bruysters M., Tesolin L., Oppling V., and Garcia D. , 16/11/2022, EDQM, strasbourg, p.12, (2022)
Training on biological methods (Immunology), Auquier, J., Domicent C., Masquelier F., Clouet S., and Tesolin L. , 13/10/2022, Sciensano, Bruxelles, (2022)
The vaccine Batch release procedure in Europe, Tesolin, L. , Seminaire ULB Pharmacien d'industrie, 05/12/2022, ULB pharmacie, (2022)
"WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", Lei, D., Meyer H., Jivapaisarnpong T., and Tesolin L. , "WHO Workshop on Implementation of Guidelines for procedures and data requirements for changes to approved vaccines", 08/11/2022, Mascate, Oman sultanate, (2022)
Workshop on implementation of single dilution assay for in vivo testing, Ribaucour, F, Florens Morgane, and Tesolin L. , Workshop on implementation of single dilution assay for in vivo testing, 22/11/2022, Brussels, Belgium, (2022)

QR code

QR code for this page URL